Edition:
United Kingdom

People: Akebia Therapeutics Inc (AKBA.OQ)

AKBA.OQ on NASDAQ Stock Exchange Global Market

4.44USD
7:17pm BST
Change (% chg)

$-0.07 (-1.55%)
Prev Close
$4.51
Open
$4.54
Day's High
$4.65
Day's Low
$4.44
Volume
108,082
Avg. Vol
340,586
52-wk High
$11.60
52-wk Low
$4.09

Amello, Jason 

Mr. Jason A. Amello has been the Chief Financial Officer, Senior Vice President and Treasurer of Akebia Therapeutics, Inc., since 2013. He joined Akebia as Senior Vice President, Chief Financial Officer and Treasurer in 2013. Prior to joining Akebia, Mr. Amello served as Executive Vice President, Chief Financial Officer and Treasurer of Ziopharm Oncology, Inc. from 2012 to 2013. From 2000 to 2011, Mr. Amello held various positions at Genzyme Corporation, most recently as Senior Vice President, Corporate Controller and Chief Accounting Officer, and led the Strategic Financial Services group through which he served as a key advisor on all of Genzyme’s mergers and acquisitions and other strategic transactions. Earlier in his career, Mr. Amello spent 10 years in the business advisory and assurance practice of Deloitte, serving in various roles of increasing responsibility through senior manager. Mr. Amello currently serves on the Board of Directors of the New England Baptist Hospital and is the Chairperson of the Quality of Care Committee and a member of the Finance and Investment Committee. Mr. Amello holds a B.A. from Boston College and is a Certified Public Accountant in the Commonwealth of Massachusetts.

Basic Compensation

Total Annual Compensation, USD 476,027
Restricted Stock Award, USD 200,200
Long-Term Incentive Plans, USD --
All Other, USD 192,991
Fiscal Year Total, USD 869,218

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Butler

3,409,220

Jason Amello

869,218

Nicole Hadas

--

Michel Dahan

1,276,790

Dell Faulkingham

--

Rita Jain

2,241,720
As Of  31 Dec 2017